Results - Announcements
Camlin Fine Sciences Ltd share price gained 2.86% to Rs 91.12. The Company's net profit fell 11.66% to Rs 29.7 crore, while revenue from operations eased by 5.46% to Rs 491.47 crore in Q3FY26 over Q2FY26.
The market capitalization of Specialty Chemicals industry group stocks on BSE stood at Rs 5.76 lakh crore, rising by 13.35%. It has improved by 2.10% over last one week and dipped slightly by 7.82% in last one month while the market capitalization of Camlin Fine Sciences Ltd has inched up 8.48% and 28.73% in the same period respectively.
Profit before tax (PBT) of Camlin Fine Sciences Ltd stood at Rs 36.51 crore in Q3 FY26, surging by 302.98% year-on-year, and easing 7.10% quarter-on-quarter. EBITDA came in at Rs 3 crore, nosediving by 108.70% YoY and plunging by 134.38% sequentially.
Total expenses marginally dropped 3.89% to Rs 509.15 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 264.2 crore, falling by 15.42% YoY, while employee benefits expense was at Rs 72.27 crore, dipping slightly 1.58% YoY.
For the TTM ended FY26, revenue from operations grew marginally by 5.81% to Rs 1723.31 crore, while net profit witnessed a sharp fall of 148.44% to Rs 31.53 crore, compared to previous TTM. EBITDA soared by 20985% to Rs 78.09 crore, and PBT tanked by 149.54% to Rs 31.99 crore compared to previous TTM.
The company's consolidated net cash flow from operating activities stood at Rs 82.07 crore in FY26, as against Rs 23.0 crore in FY25.
Camlin Fine Sciences Ltd tumbled by 54.38% in last one year, underperforming the benchmark BSE Sensex which has eased by 8.41% during the same period.